Side-by-side comparison of AI visibility scores, market position, and capabilities
Amino Health provides a data-driven healthcare navigation platform that helps employees find high-quality, in-network providers using a 26B+ claims database; raised $70M+ total;
Amino Health is a digital health company founded in 2013 and headquartered in San Francisco, California, that helps employees and health plan members find high-quality, cost-effective in-network healthcare providers using data-driven recommendations. The platform is powered by a proprietary database of more than 26 billion de-identified medical claims, which enables Amino to estimate physician quality, specialty expertise, and patient cost outcomes based on actual historical treatment data rather than self-reported information or generic star ratings.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.